Subsequent Entry Biologics and Biologics - An Introductory Education Program for Pharmacists

Online

Summary

Biologics and Subsequent-Entry Biologics (SEBs) are revolutionary drugs that assist in the management of many chronic conditions that pharmacists see in their patients. This online professional development program gives participants a foundation-level awareness and understanding of biologics and SEBs and their role in patient care. The session also explores and clarifies the meaning of a SEB, an increasingly common term in pharmacy practice. Additionally, the differences between innovator biologics and SEBs are reviewed, as well as the implications of changing between biologics and SEBs.


Upon completion of this program, participants will be able to:

•Discuss the history of biologics

•Briefly describe how biologics are manufactured

•List key differences between innovator biologics and SEBs

•Explain how SEBs and innovator biologics are named using INN (International Non-proprietary Naming)

•Describe the differences between generic drugs and SEBs

•Discuss factors that need to be considered when a prescription for a biologic is received

•Explain how Health Canada regulates SEBs

•Explain whether or not biologics and SEBs are interchangeable, and reasons behind such

•Describe the implications of changing between biologics and SEBs


For More Information

Inquiries: Please contact OPA’s professional development team by phone at 416-441-0788, option 3 (toll-free in Ontario at 1-877-341-0788, option 3), or by email at education@opatoday.com

Website: https://www.opatoday.com/224101